Asymmetric synthesis of structural analogues of (+)-clusianone via enantioselective ACC alkylation

Tetrahedron Letters

Volumn 56, Issue 23, 2015, Pages 3183-3185

  Garnsey, Michelle R ^a   Uteuliyev, Maulen M ^a   Coltart, Don M ^a  

^a University of Houston   (United States)

Author keywords

ACC ketone alkylation; Asymmetric synthesis; Polycyclic polyprenylated acylphloroglucinols; Viral infection

Indexed keywords

ANTIVIRUS AGENT; CLUSIANONE DERIVATIVE; UNCLASSIFIED DRUG;

ALKYLATION; ARTICLE; ASYMMETRIC SYNTHESIS; DIASTEREOISOMER; DRUG STRUCTURE; DRUG SYNTHESIS; ENANTIOSELECTIVITY;

EID: 84929955380     PISSN: 00404039     EISSN: 18733581     Source Type: Journal    
DOI: 10.1016/j.tetlet.2015.01.012     Document Type: Article

References (27)

1. C. Walsh Nature 406 2006 775 781
2. J.F. Fisher, S.O. Meroueh, and S. Mobashery Chem. Rev. 105 2005 395 424
3. L. Strasfeld, and S. Chou Infect. Dis. Clin. North Am. 24 2010 809 833
4. R. Ciochina, and R.B. Grossman Chem. Rev. 106 2006 3963 3986
5. A.L. Piccinelli, O. Cuesta-Rubio, M.B. Chica, N. Mahmood, B. Pagano, M. Pavone, V. Barone, and L. Rastrelli Tetrahedron 61 2005 8206 8211
6. C. Ito, M. Itoigawa, Y. Miyamoto, S. Onoda, K.S. Rao, T. Mukainaka, H. Tokuda, H. Nishino, and H. Furukawa J. Nat. Prod. 66 2003 206 209
7. M.R. Garnsey, D. Lim, J.M. Yost, and D.M. Coltart Org. Lett. 12 2010 5234 5237
8. D. Lim, and D.M. Coltart Angew. Chem., Int. Ed. 47 2008 5207 5210
9. E.H. Krenske, K.N. Houk, D. Lim, S.E. Wengryniuk, and D.M. Coltart J. Org. Chem. 75 2010 8578 8584
10. S.E. Wengryniuk, D. Lim, and D.M. Coltart J. Am. Chem. Soc. 133 2011 8714 8720
11. M.R. Garnsey, J.A. Matous, J.J. Kwiek, and D.M. Coltart Bioorg. Med. Chem. Lett. 21 2011 2406 2409
12. For previous racemic syntheses of clusianone, see: (a) V. Rodeschini, N.M. Ahmad, and N.S. Simpkins Org. Lett. 8 2006 5283 5285
13. C. Tsukano, D.R. Siegel, and S.J. Danishefsky Angew. Chem. 119 2007 8996 9000
14. N.M. Ahmad, V. Rodeschini, N.S. Simpkins, S.E. Ward, and A.J. Blake J. Org. Chem. 72 2007 4803 4815
15. J. Qi, and J.A. Porco Jr. J. Am. Chem. Soc. 129 2007 12682 12683
16. P. Nuhant, M. David, T. Pouplin, B. Delpech, and C. Marazano Org. Lett. 9 2007 287 289
17. M. Uwamori, and M. Nakada Nat. Prod. Commun. 66 2013 141 145
18. For previous asymmetric syntheses of clusianone, see: (a) V. Rodeschini, N.S. Simpkins, and C. Wilson J. Org. Chem. 72 2007 4265 4267
19. M.R. Garnsey, J.A. Matous, J.J. Kwiek, and D.M. Coltart Bioorg. Med. Chem. Lett. 21 2011 2406 2409
20. J.H. Boyce, and J.A. Porco Jr. Angew. Chem., Int. Ed. 53 2014 7832 7837
21. Simple modifications to PPAP ring structures have been shown to have a large effect on their biological activity. See, for example, Ref. 3.
22. R.D. Clark, and C.H.J. Heathcock Org. Chem. 41 1976 636 643
23. Refs. 6,8, and unpublished results.
24. Established by HPLC using a chiral, non-racemic stationary phase by comparison to an independently prepared racemic sample of 16 under conditions that gave baseline separation of its enantiomers (see Ref. 6 for details).
25. W.G. Dauben, and D.M. Michno J. Org. Chem. 42 1977 682 685
26. J.H. Babler, and M.J. Coghlan Synth. Commun. 6 1976 469 474
27. K.H. Schonwalder, P. Kollat, J.J. Stezowski, and F. Effenberger Chem. Ber. 117 1984 3280 3296